Prevention of arterial thrombosis by nobiletin: In vitro and in vivo studies

Journal of Nutritional Biochemistry

Volumn 28, Issue , 2016, Pages 1-8

  Lu, Wan Jung ^a,b,c   Lin, Kao Chang ^a,d   Liu, Chun Ping ^e   Lin, Chia Ying ^a   Wu, Hsh Chu ^a   Chou, Duen Suey ^a   Geraldine, Pitchairaj ^f   Huang, Shih Yi ^c   Hsieh, Cheng Ying ^a   Sheu, Joen Rong ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e YUAN'S GENERAL HOSPITAL   (Taiwan)

^f BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Akt; Arterial thrombosis; Citrus fruits; Hydroxyl radical; Nobiletin

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; CALCIUM; HYDROXYL RADICAL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NOBILETIN; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE B; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE 1; FLAVONE DERIVATIVE; PHOSPHOLIPASE C GAMMA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY THROMBOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; ARTERY; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM; PATHOLOGY; THROMBOSIS; YOUNG ADULT;

ADULT; ARTERIES; ENZYME ACTIVATION; FLAVONES; HUMANS; IN VITRO TECHNIQUES; PHOSPHOLIPASE C GAMMA; PLATELET AGGREGATION; PROTEIN KINASE C; THROMBOSIS; YOUNG ADULT;

EID: 84952765703     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.09.024     Document Type: Article

References (34)

1. Chen J., Montanari A.M., Widmer W.W. Two new polymethoxylated flavones, a class of compounds with potential anticancer activity, isolated from cold pressed dancy tangerine peel in solids. J Agric Food Chem 1997, 45:364-368.
2. Nogata U., Sakamoto K., Shiratsuchi H., Ishi T., Yano M., Ohta H. Flavonoid composition of fruit tissues of citrus species. Biosci Biotechnol Biochem 2006, 70:178-192.
3. Murakami A., Nakamura Y., Torikai K., Tanaka T., Koshiba T., Koshimizu K., et al. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation oxidative stress, and tumor promotion in mice. Cancer Res 2000, 60:5059-5066.
4. Lin N., Sato T., Takayama Y., Mimaki Y., Sashida Y., Yano M., et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol 2003, 65:2065.
5. Ishiwa J., Sato T., Mimaki Y., Sashida Y., Yano M., Ito A. A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J Rheumatol 2000, 27:20.
6. Lee Young-Sil, Byung-Yoon Cha, Kiyoto Saito, Hiroshi Yamakawa, Sun-Sil Choi, Kohji Yamaguchi, et al. Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem Pharmacol 2010, 79:1674-1683.
7. Kandaswami C., Perkins E., Soloniuk D.S., Drzewiecki G., Middleton E. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett 1991, 56:147.
8. Yoshimizu N., Otani Y., Saikawa Y., Kubota T. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment Pharmacol Ther 2004, 20:95.
9. Manthey J.A., Guthrie N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem 2002, 50:5837.
10. Peluso M.R. Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp Biol Med (Maywood) 2006, 231:1287-1299.
11. Sheu J.R., Lee C.R., Lin C.H., Hsiao G., Ko W.C., Chen Y.C., et al. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb Haemost 2000, 83:777-784.
12. Whitman S.C., Kurowska E.M., Manthey J.A., Daugherty A. Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages. Atherosclerosis 2005, 178:25-32.
13. Eguchi A., Murakami A., Ohigashi H. Nobiletin, a citrus flavonoid, suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-human monocytic cells. FEBS Lett 2006, 580:3321-3328.
14. Zhou C.H., Wu X.H., Wu Y.Q. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway. Eur J Pharmacol 2009, 615:55-60.
15. Chou D.S., Hsiao G., Shen M.Y., Tsai Y.J., Chen T.F., Sheu J.R. ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets. Free Radic Biol Med 2005, 39:237-248.
16. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001, 138:152-163.
17. Hsiao G., Lin K.H., Chang Y., Chen T.L., Tzu N.H., Chou D.S., et al. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage. Arterioscler Thromb Vasc Biol 2005, 25:1998-2004.
18. Singer W.D., Brown H.A., Sternweis P.C. Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D. Annu Rev Biochem 1997, 66:475-509.
19. Kumar A., Devaraj V.C., Giri K.C., Giri S., Rajagopal S., Mullangi R. Development and validation of a highly sensitive LC-MS/MS-ESI method for the determination of nobiletin in rat plasma: application to a pharmacokinetic study. Biomed Chromatogr 2012, 26:1464-1471.
20. Mangin P., Yuan Y., Goncalves I., Eckly A., Freund M., Cazenave J.P., et al. Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. J Biol Chem 2003, 278:32880-32891.
21. Pascale A., Amadio M., Govoni S., Battaini F. The aging brain, a key target for the future: the protein kinase C involvement. Pharmacol Res 2007, 55:560-569.
22. Ragab A., Severin S., Gratacap M.P., Aguado E., Malissen M., Jandrot-Perrus M., et al. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC gamma 2 activation. Blood 2007, 110:2466-2474.
23. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
24. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
25. Bugaud F., Nadal-Wollbold F., Levy-Toledano S., Rosa J.P., Bryckaert M. Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 1999, 94:3800-3805.
26. Hughes P.E., Renshaw M.W., Pfaff M., Forsyth J., Keivens V.M., Schwartz M.A., et al. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 1997, 88:521-530.
27. 2 cascade in hydroperoxide-stressed platelets. Free Radic Biol Med 2003, 35:616-625.
28. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81:727-736.
29. Chen J., De S., Damron D.S., Chen W.S., Hay N., Byzova T.V. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004, 104:1703-1710.
30. Woulfe D., Jiang H., Morgans A., Monks R., Birnbaum M., Brass L.F. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004, 113:441-450.
31. Woulfe D.S. Akt signaling in platelets and thrombosis. Expert Rev Hematol 2010, 3:81-91.
32. Jayakumara T., Chen W.F., Lu W.J., Chou D.S., Hsiao G., Hsu C.Y., et al. A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies. J Nutr Biochem 2013, 24:1086-1095.
33. Walter U., Eigenthaler M., Geiger J., Reinhard M. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. Adv Exp Med Biol 1993, 344:237-249.
34. Sheu J.R., Hung W.C., Wu C.H., Ma M.C., Kan Y.C., Lin C.H., et al. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation 1999, 99:3056-3062.